Michael F. Demane - Sep 30, 2023 Form 4 Insider Report for NEVRO CORP (NVRO)

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael F. DeMane
Stock symbol
NVRO
Transactions as of
Sep 30, 2023
Transactions value $
$0
Form type
4
Date filed
10/3/2023, 04:55 PM
Previous filing
Jul 5, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +1.37K +4.74% $0.00 30.2K Sep 30, 2023 Direct F1, F2
holding NVRO Common Stock 164K Sep 30, 2023 See footnote F3
holding NVRO Common Stock 123K Sep 30, 2023 See footnote F4
holding NVRO Common Stock 131K Sep 30, 2023 See footnote F5
holding NVRO Common Stock 18.3K Sep 30, 2023 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
F2 Includes 6,754 restricted stock units.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.